AU2003235395A1 - Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water - Google Patents

Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water

Info

Publication number
AU2003235395A1
AU2003235395A1 AU2003235395A AU2003235395A AU2003235395A1 AU 2003235395 A1 AU2003235395 A1 AU 2003235395A1 AU 2003235395 A AU2003235395 A AU 2003235395A AU 2003235395 A AU2003235395 A AU 2003235395A AU 2003235395 A1 AU2003235395 A1 AU 2003235395A1
Authority
AU
Australia
Prior art keywords
water
pharmaceutical preparation
slightly soluble
dissolving property
preparation improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003235395A
Inventor
Shuichi Matsuda
Hidekazu Syodai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2003235395A1 publication Critical patent/AU2003235395A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003235395A 2002-05-22 2003-05-21 Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water Abandoned AU2003235395A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-147113 2002-05-22
JP2002147113 2002-05-22
PCT/JP2003/006346 WO2003097102A1 (en) 2002-05-22 2003-05-21 Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water

Publications (1)

Publication Number Publication Date
AU2003235395A1 true AU2003235395A1 (en) 2003-12-02

Family

ID=29545163

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003235395A Abandoned AU2003235395A1 (en) 2002-05-22 2003-05-21 Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water

Country Status (4)

Country Link
JP (2) JP4743684B2 (en)
AU (1) AU2003235395A1 (en)
TW (1) TW200306868A (en)
WO (1) WO2003097102A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003235395A1 (en) * 2002-05-22 2003-12-02 Shionogi And Co., Ltd. Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water
US8168228B2 (en) * 2003-10-17 2012-05-01 Sandoz Ag Antibiotic clarithromycin micropellet compositions
WO2006115285A1 (en) * 2005-04-21 2006-11-02 Takeda Pharmaceutical Company Limited Pharmaceutical composition
JP2008230967A (en) * 2005-06-23 2008-10-02 Kowa Co Pharmaceutical composition
KR20080071557A (en) * 2005-11-24 2008-08-04 오노 야꾸힝 고교 가부시키가이샤 Solid pharmaceutical preparation and pharmaceutical preparation composition
MX2009010474A (en) * 2007-03-29 2009-10-19 Daiichi Sankyo Co Ltd Pharmaceutical composition.
CN102481248B (en) * 2009-04-30 2013-12-11 武田药品工业株式会社 Solid preparation
CA2793525C (en) 2010-03-19 2014-05-06 Daiichi Sankyo Company, Limited Method for improving dissolution of anticoagulant agent
JPWO2013022059A1 (en) 2011-08-10 2015-03-05 第一三共株式会社 Pharmaceutical composition containing diamine derivative
JP6411265B2 (en) * 2015-03-30 2018-10-24 共和薬品工業株式会社 Entacapone-containing pharmaceutical composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3006901B2 (en) * 1991-03-29 2000-02-07 塩野義製薬株式会社 Coated preparation
JPH0717866A (en) * 1993-06-16 1995-01-20 Meiji Seika Kaisha Ltd Medicinal composition
AR004014A1 (en) * 1995-10-13 1998-09-30 Meiji Seika Kaisha AN ANTIBACTERIAL COMPOSITION OF CEFDITOREN PIVOXILO FOR ORAL ADMINISTRATION AND METHOD TO OBTAIN SUCH COMPOSITION
JPH09309829A (en) * 1996-05-22 1997-12-02 Taiyo Yakuhin Kogyo Kk Oral administration preparation containing nitrendipine and its production
JPH10147524A (en) * 1996-09-20 1998-06-02 Nippon Kayaku Co Ltd Forskolin derivative-containing oral preparation and production of medicine preparation
JP3770518B2 (en) * 1997-03-28 2006-04-26 エーザイ株式会社 Oral drugs concealing bitterness
KR100693266B1 (en) * 1997-03-28 2007-03-27 에자이 가부시키가이샤 Oral pharmaceutical preparations decreased in bitterness by masking
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
JP4117811B2 (en) * 1997-04-22 2008-07-16 日本化薬株式会社 Flutamide preparation and its production method
CA2318421A1 (en) * 1998-01-14 1999-07-22 Toshio Murakami Disintegrating agent
JP2000178182A (en) * 1998-12-17 2000-06-27 Lion Corp Disintegrable composition
JP2000178184A (en) * 1998-12-17 2000-06-27 Lion Corp Granular composition, and production of tablet and granular composition
JP2000273039A (en) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd Composition disintegrable in oral cavity
JP2001316249A (en) * 2000-05-11 2001-11-13 Lion Corp Tablet-type medicinal composition
JP2002087965A (en) * 2000-09-14 2002-03-27 Lion Corp In-mouth disintegrable aspirin-containing tablet
AU2003235395A1 (en) * 2002-05-22 2003-12-02 Shionogi And Co., Ltd. Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water

Also Published As

Publication number Publication date
JP4743684B2 (en) 2011-08-10
JPWO2003097102A1 (en) 2005-09-15
WO2003097102A1 (en) 2003-11-27
JP2010090175A (en) 2010-04-22
TW200306868A (en) 2003-12-01

Similar Documents

Publication Publication Date Title
TWI349664B (en) Benzimidazole derivatives: preparation and pharmaceutical applications
IL173527A0 (en) Pharmaceutical composition containing water soluble drug
HK1254279A1 (en) Pharmaceutical preparation containing oxycodone and naloxone
IL163894A (en) 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments
AU2009201465A1 (en) Pharmaceutical Compositions with Improved Dissolution
HK1093508A1 (en) Derivatives of diperdinyl-and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in preparation of drugs
IL173195A0 (en) Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them
HK1083749A1 (en) Solid nano pharmaceutical formulation and preparation method thereof
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2003235395A1 (en) Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water
IL152900A0 (en) Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
AU2003292509A1 (en) Taste masked pharmaceutical compositions comprising bitter drug and ph sensitive polymer
SI1673349T1 (en) Benzimidazole derivatives: preparation and pharmaceutical applications
AU2003267231A1 (en) Pharmaceutical compositions with improved dissolution
AU2003207461A1 (en) Drug mixture with enhanced dissolution rate
AU2003260239A1 (en) Solid dosage forms for rapid dissolution of poorly soluble drugs
AU6038601A (en) Amino acid derivatives and their use as medicines
IL166098A0 (en) 3-guanindinocarbonyl-1-heteroaryl-indole derivatives preparation process their use as medicaments and pharmaceutical compositions comprising them
AU2002349506A1 (en) Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions
IL172087A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
AU2003257982A1 (en) Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
AU2003256157A1 (en) Oral dosage forms of water insoluble drugs and methods of making the same
EP1620088A4 (en) Indole acetic acid derivatives and their use as pharmaceutical agents
AU2003280387A1 (en) Pharmaceutical formulation comprising azithrocycin monohydrate
EP1661556A4 (en) Medicinal preparation having improved dissolution properties

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase